Cell Culture Medium Buffering for CO2 Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Biopharmaceutical process development for eukaryotic cells faces challenges in maximizing product titers and productivity, particularly in mammalian cell systems, due to limitations in process control during fermentation and medium optimization, with existing methods relying on sodium hydrogen carbonate as a buffer that can lead to pH instability and cell toxicity.
Innovation Solution
A method involving a cell culture medium without HCO3- or CO32- ions, using sodium-β-glycerophosphate pentahydrate as a buffer, and independent control of pCO2 through CO2, O2, and air supply, allowing for decoupling of pCO2 control from pH and gassing, enabling optimal CO2 profiles for different growth phases and scalability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If sodium hydrogen carbonate (NaHCO3) is used as a buffer in cell culture medium, then pH stability is improved, but cell toxicity increases and product formation rate decreases
Solution Approach 1:
The patent removes sodium hydrogen carbonate (NaHCO3) from the cell culture medium, extracting the harmful buffering component while replacing it with alternative buffers (sodium phosphate, HEPES, or TES) that do not exhibit the same toxic effects on mammalian cells and do not interfere with product formation
Solution Approach 2:
The patent changes the buffering parameters by substituting NaHCO3 with different buffer systems (phosphate buffer at pH 7.2-7.4, HEPES at pH 7.0-7.4, or TES at pH 7.0-7.4) with optimized concentrations, thereby altering the chemical environment to eliminate toxicity while maintaining pH stability
2Adaptability or versatility
If pCO2 control is decoupled from pH and gassing control, then process optimization and scalability are improved, but system complexity increases
Solution Approach 1:
The patent segments the control system into independent modules: pH control (via base addition), pCO2 control (via gas phase management), and gassing control (via sparging), allowing each parameter to be optimized independently without interfering with the others, thereby enabling better process optimization and scalability
Solution Approach 2:
The patent implements dynamic control where pCO2 is regulated independently through the relationship pCO2 = f(pH, pO2, T, stirring speed, gas flow), allowing the system to adapt to changing process conditions in real-time while maintaining optimal parameters for cell growth and product formation
3Productivity
If fermentation time is extended to increase product yield, then productivity is improved, but process control stability becomes more difficult to maintain
Solution Approach 1:
The patent extends the fermentation process duration by eliminating the toxic effects of NaHCO3, which allows cells to maintain healthy metabolic function and continue productive protein synthesis for longer periods without experiencing toxicity-induced stress or death, thereby achieving higher overall yields while maintaining control stability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances specific product formation rates, extends fermentation time, improves reproducibility, and allows for independent optimization of process variables, leading to higher product yields and reduced cell toxicity, while maintaining comparable performance across different scales.
Implementation Method 1
using sodium-β-glycerophosphate pentahydrate as a buffer
Implementation Method 2
independent control of pCO2 through CO2, O2, and air supply
Data Source
Figure 1
Figure 2A
Figure 2B
AI summary
The invention relates to the development of a new buffer system for cell culture media for establishing a CO2 control in the bioreactor using eukaryotic cells. This technology allows a CO2 control for the purpose of process control, process optimization and scaling. The invention further relates to a specific cell culture medium comprising specific buffer substances.